Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Qiweiqingyan aerosol in acute pharyngitis
ChiCTR-IPR-15005991Phase 4Not yet recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Mar 2015
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Qiwei Qingyan in acute pharyngitis (3 arms), sponsored by West China Hospital of Sichuan University. Primary endpoints: Time to complete resolution of sore throat and Relief rate of sore throat. Planned start Mar 2015; status: not yet recruiting.
02
Drugs
Qiwei Qingyan
03
Conditions
acute pharyngitis
Beyond the preview
Go deeper on ChiCTR-IPR-15005991.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-15005991.